Kristen Coppock Crossley
LightNews LightNews
kcoppockcrossley.bsky.social
Kristen Coppock Crossley
@kcoppockcrossley.bsky.social
38 followers 9 following 6 posts
Health care journalist and multimedia content creator.
Posts Replies Media Videos
kcoppockcrossley.bsky.social
The #EuropeanCommission has granted marketing authorization for a single-injection drug for managing canine pain associated with osteoarthritis.

www.dvm360.com/view/long-ac...

#Zoetis @ec.europa.eu
Long-acting drug for reducing canine OA pain receives European marketing authorization | dvm360
The single-injection monoclonal antibody (Lenivia) from Zoetis reduces OA pain in dogs for 3 months.
www.dvm360.com
December 1, 2025 at 5:32 PM
kcoppockcrossley.bsky.social
An infectious disease outbreak may have started at a rodeo event in Texas, and has spread to multiple states.

Read more: www.dvm360.com/view/equine-...
Equine herpesvirus poses threat to horses in multiple states | dvm360
The highly contagious virus has been linked to a recent rodeo event, with known cases diagnosed in horses from Texas and Oklahoma.
www.dvm360.com
November 25, 2025 at 9:37 PM
kcoppockcrossley.bsky.social
#DalanAnimalHealth was granted a conditional license for an American foulbrood vaccine in 2023, from the #USDA and continue to work toward full licensure. Recent efficacy trials support that goal for #honeybeehealth.

Read more: www.dvm360.com/view/vaccine...

@usdagov.bsky.social
Vaccine for honeybees successfully completes efficacy trials | dvm360
The study results place the American foulbrood prevention therapy closer to full USDA licensure.
www.dvm360.com
November 14, 2025 at 3:02 PM
kcoppockcrossley.bsky.social
Two universities are getting closer to opening their veterinary schools, while researchers at several other universities work to advance veterinary medicine. Read my dvm360® newsletter for these stories and more veterinary academia news.

www.linkedin.com/pulse/study-...

@cupress.bsky.social
Study Break with dvm360®
Grab a coffee and catch up on recent advancements in veterinary education, student experience, clinical care, and more industry news from colleges and schools at the forefront of shaping the future of...
www.linkedin.com
November 3, 2025 at 4:37 PM
kcoppockcrossley.bsky.social
A new generic antimicrobial for dogs has been approved by the FDA for treating skin infections.

Read more: www.dvm360.com/view/generic...

#Felixvet #CefpodoximeProxetil
Generic antimicrobial product is approved by the FDA | dvm360
Felixvet has announced the approval for a bioequivalent product to Simplicef (Zoetis).
www.dvm360.com
October 31, 2025 at 5:43 PM
kcoppockcrossley.bsky.social
A clinical trial has been launched for a novel cancer drug for dogs. This injectable therapy targets PD-L1 in patients with solid tumors.

Read more: www.dvm360.com/view/akston-...

#PetCancer #Akston @pucvm.bsky.social
📷 Akston Biosciences
Akston launches clinical trial for novel canine cancer therapy | dvm360
The Akston Biosciences Corporation partnered with Purdue University to develop a drug targeting PD-L1 in dogs with solid tumors.
www.dvm360.com
October 30, 2025 at 5:41 PM